Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SoftOx Solutions AS Proxy Solicitation & Information Statement 2026

Jun 9, 2026

3747_rns_2026-06-09_96960435-94b7-415e-a31c-aa4c7e6a47e1.html

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

SoftOx Solutions AS: Notice of General Assembly

SoftOx Solutions AS: Notice of General Assembly

SoftOx Solutions AS will hold a General Meeting on 24th June 2026 at 10 am (CEST). The notice convening the General Meeting, including the agenda and the board's proposals for the matters to be dealt with, is enclosed with this notification and will be sent to all shareholders.

Relevant documents referred to in the notice are also made available at

https://soft-ox.com/stock-market-announcements/

For further information, please contact:

Ulrik Spork, COB Soft Solutions AS, +45 31 38 83 87

Ingrid Juven, CFO SoftOx Solutions AS, +47 918 76 165

Mail: [email protected]

About SoftOx Solutions AS:

SoftOx Solutions AS (ticker: SOFTX) is a clinical-stage pharmaceutical company developing SIS (SoftOx Inhalation Solution), a novel inhaled anti-infective therapy for the treatment of respiratory infections in the airways and lungs. The Company is listed on Euronext Growth Oslo.